Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) - Anna-Theresa Schulze; Timo Schurr; Fabienne Post; Beatrice Frajo-Apor; Covadonga M. Díaz-Caneja; Walter Wolfgang Fleischhacker; Michael Davidson; Alex Hofer (European Psychiatry)